Dr. Edward Fry, new President of the American College of Cardiology, discusses the results of the POISE-3 trial, which investigated the efficacy and safety of tranexamic acid in patients undergoing noncardiac surgery.
Reduction of Bleeding with Tranexamic Acid After Noncardiac Surgery
Share
Save
Restart
Resume
Share this program on:
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Details
Recommended
Details
Overview
Dr. Edward Fry, new President of the American College of Cardiology, discusses the results of the POISE-3 trial, which investigated the efficacy and safety of tranexamic acid in patients undergoing noncardiac surgery.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?